Paper · 39716914
Glycerol-3-phosphate contributes to the increase in FGF23 production in chronic kidney disease.
Simic P and 7 others. Am J Physiol Renal Physiol, 2025. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glycerol-3-phosphate contributes to the increase in FGF23 production in chronic kidney disease. Papers, record 39716914. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39716914
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycerol-3-phosphate contributes to the increase in FGF23 production in chronic kidney disease.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Renal Insufficiency, Chronic | Major topic |
| Fibroblast Growth Factors | Major topic |
| Glycerophosphates | Major topic |
| Kidney | Major topic |
| Animals | |
| Fibroblast Growth Factor-23 | |
| Male | |
| Mice, Knockout | |
| Glycerolphosphate Dehydrogenase | |
| Rats | |
| Adenine | |
| Disease Models, Animal | |
| Mice | |
| Mice, Inbred C57BL | |
| Rats, Sprague-Dawley | |
| Phosphates |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AR075042 | NIAMS NIH HHS | United States | P30AR075042 | PubMed and NIH | NIH RePORTER |
| R01 DK130291 | NIDDK NIH HHS | United States | R01DK130291 | PubMed and NIH | NIH RePORTER |
| K08DK124568 | HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | K08DK124568 | PubMed and NIH | NIH RePORTER | |
| K08 DK124568 | NIDDK NIH HHS | United States | K08DK124568 | PubMed and NIH | NIH RePORTER |
| R01DK130291 | HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | R01DK130291 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,661,434 | Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism. | Curr Opin Nephrol Hypertens | 2024 | https://conductscience.org/library/papers/38661434 | PubMed |
| 2 | 31,668,375 | Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. | Am J Kidney Dis | 2020 | https://conductscience.org/library/papers/31668375 | PubMed |
| 3 | 24,385,590 | Renal cortical pyruvate depletion during AKI. | J Am Soc Nephrol | 2014 | https://conductscience.org/library/papers/24385590 | PubMed |
| 4 | 34,185,705 | Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34185705 | PubMed |
| 5 | 15,917,335 | Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. | J Am Soc Nephrol | 2005 | https://conductscience.org/library/papers/15917335 | PubMed |
| 6 | 31,602,417 | New concepts in feedback regulation of glucose metabolism. | Curr Opin Syst Biol | 2018 | https://conductscience.org/library/papers/31602417 | PubMed |
| 7 | 36,190,819 | Vascular calcification maladaptively participates in acute phosphate homeostasis. | Cardiovasc Res | 2023 | https://conductscience.org/library/papers/36190819 | PubMed |
| 8 | 29,482,575 | i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases. | Genome Biol | 2018 | https://conductscience.org/library/papers/29482575 | PubMed |
| 9 | 32,065,590 | Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32065590 | PubMed |
| 10 | 32,001,068 | Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts. | Kidney Int | 2020 | https://conductscience.org/library/papers/32001068 | PubMed |
1 to 10 of 25
See all 25 referencesCited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,663,891 | FGF23 - A hormone produced by bone and has many faces. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/42663891 | PubMed |
| 42,020,815 | Broken signals: when the mineralostat alters the cardiovascular system. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42020815 | PubMed |
| 41,767,622 | Markers of Mineral Metabolism in Children With CKD Stages 2 to 5D. | Kidney Int Rep | 2026 | https://conductscience.org/library/papers/41767622 | PubMed |
| 41,699,300 | A genetically encoded bifunctional enzyme mitigates redox imbalance and lipotoxicity. | Nat Metab | 2026 | https://conductscience.org/library/papers/41699300 | PubMed |
| 41,683,565 | High-Phosphate-Induced Hypertension: The Pathogenic Role of Fibroblast Growth Factor 23 (FGF23) Signaling in Sympathetic Nervous System Activation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683565 | PubMed |
| 41,105,473 | Association between Serum Glycerol-3-Phosphate and Fibroblast Growth Factor-23 in Nondiabetic Patients on Hemodialysis. | Clin J Am Soc Nephrol | 2026 | https://conductscience.org/library/papers/41105473 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGF23 | 8,074 | PubTator's text mining | https://conductscience.org/library/genes/8074 | NCBI Gene |
| GPD1 | 2,819 | PubTator's text mining | https://conductscience.org/library/genes/2819 | NCBI Gene |
| PTH | 5,741 | PubTator's text mining | https://conductscience.org/library/genes/5741 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39716914
GET https://conductscience.org/api/papers/v1/39716914/references?page=2